Literature DB >> 3964778

Effect of 16,16-dimethyl prostaglandin E2 on the surface hydrophobicity of aspirin-treated canine gastric mucosa.

L M Lichtenberger, J E Richards, B A Hills.   

Abstract

The canine gastric mucosa has a uniquely hydrophobic or nonwettable surface that is rapidly disrupted by damaging agents such as aspirin. In this study we investigated the effects of acidified aspirin on the wettability of the luminal surface of gastric mucosae mounted in Ussing chambers in the presence of varying concentrations of 16,16-dimethyl prostaglandin E2. It was determined that surface hydrophobicity of the stomach, as measured by contact angle measurements, could be reduced by 50% with an aspirin concentration of 5 mM in the mucosal bath and that this change could be completely and significantly reversed by the addition of 16,16-dimethyl prostaglandin E2 (1 microgram/ml) to the nutrient compartment. 16,16-Dimethyl prostaglandin E2 at this dose was less effective in restoring the surface hydrophobicity in response to a higher concentration of aspirin (20 mM) that abolished the nonwettable property of the tissue. The reduced surface hydrophobicity in the presence of 5 mM aspirin could be increased in a dose response relationship to the nutrient 16,16-dimethyl prostaglandin E2 concentration, with an effect being seen at doses as low as 1 ng/ml. These results support the concept that prostaglandins may protect the stomach by the maintenance of a nonwettable hydrophobic lining between damaging agents in the lumen and the gastric epithelium.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3964778     DOI: 10.1016/s0016-5085(85)80185-2

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  23 in total

Review 1.  Mechanisms of NSAID-induced gastroenteropathy.

Authors:  A H Price; M Fletcher
Journal:  Drugs       Date:  1990       Impact factor: 9.546

Review 2.  Non-steroidal anti-inflammatory drug-induced gastropathy. Mechanisms and management.

Authors:  S Szabo; W F Spill; K D Rainsford
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Mar-Apr

3.  Asthma: is there an airway receptor barrier?

Authors:  B A Hills
Journal:  Thorax       Date:  1996-08       Impact factor: 9.139

4.  Gastric surfactant and the hydrophobic mucosal barrier.

Authors:  B A Hills
Journal:  Gut       Date:  1996-11       Impact factor: 23.059

5.  Effect of enprostil on amphibian gastroduodenal and human gastric bicarbonate secretion.

Authors:  C J Shorrock; L C Gibbons; W D Rees
Journal:  Dig Dis Sci       Date:  1989-07       Impact factor: 3.199

6.  Phospholipid composition of human gastric mucosa: a study of endoscopic biopsy specimens.

Authors:  G Nardone; P Laccetti; C Civiletti; G Budillon
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

7.  Age and Helicobacter pylori decrease gastric mucosal surface hydrophobicity independently.

Authors:  A Hackelsberger; U Platzer; M Nilius; V Schultze; T Günther; J E Dominguez-Muñoz; P Malfertheiner
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

8.  Mucosal adaptation to indomethacin induced gastric damage in man--studies on morphology, blood flow, and prostaglandin E2 metabolism.

Authors:  C J Shorrock; W D Rees
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

Review 9.  Mucosal coating agents and other nonantisecretory agents. Are they cytoprotective?

Authors:  P H Guth
Journal:  Dig Dis Sci       Date:  1987-06       Impact factor: 3.199

10.  Effect of luminal pH on the output of bicarbonate and PGE2 by the normal human stomach.

Authors:  J R Crampton; L C Gibbons; W D Rees
Journal:  Gut       Date:  1987-10       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.